SMTI NASDAQ
Sanara MedTech Inc.
1W: -0.9%
1M: -6.4%
3M: +8.6%
YTD: +42.2%
1Y: +5.7%
3Y: +17.4%
5Y: -5.9%
$32.84
-0.18 (-0.55%)
Pre-Market: $36.45 (+3.61, +10.99%)
Weekly Expected Move ±2.8%
$31
$32
$33
$34
$35
Credit Risk of going bust: higher than 55% of companies Debt: 13.9% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.59 (down 98%), Sanara MedTech Inc. would be worth roughly what it owes.
Total debt $48.5M against a stock market value of $301.7M.
Distance to default 4.65 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $23.2M (short-term plus half of long-term), stock volatility 58.4%; Altman Z 3.72. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.59 (down 98%), Sanara MedTech Inc. would be worth roughly what it owes.
Total debt $48.5M against a stock market value of $301.7M.
Distance to default 4.65 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $23.2M (short-term plus half of long-term), stock volatility 58.4%; Altman Z 3.72. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (33)
Sanara MedTech Inc. (NASDAQ:SMTI) Stock Has Consensus Target Price of $35.00 According to Analysts
Sanara MedTech/MiMedx deal spread widens on FTC second request.
15,945 Shares of Sanara MedTech Inc. $SMTI Bought by Bank of America Corp DE
Sanara MedTech Inc. (NASDAQ:SMTI) Stock Has Consensus Price Target of $35.00
BlackRock Inc. Takes $5.87 Million Position in Sanara MedTech Inc. $SMTI
MiMedx rises after Craig-Hallum raises price target on Sanara Deal
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates
biote Corp. (BTMD) Reports Break-Even Earnings for Q2
Sanara MedTech Inc. (NASDAQ:SMTI) Receives $34.00 Average PT from Analysts
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript
SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law Firm
ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates
Insulet (PODD) Q1 Earnings and Revenues Top Estimates
Sanara MedTech (SMTI) Q4 2025 Earnings Transcript
Q1 EPS Estimates for Sanara MedTech Lowered by HC Wainwright
Q4 EPS Estimates for Sanara MedTech Reduced by HC Wainwright
Sanara MedTech outlines 2026 net revenue guidance of $116M–$121M while expanding distributor network and product reach
Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates
Sanara MedTech GAAP EPS of -$0.19, revenue of $27.5M
Earnings Scheduled For March 24, 2026
Sanara MedTech (NASDAQ:SMTI) Trading Up 0.8% – Here’s What Happened
Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates
Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance
Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution
Sanara MedTech (SMTI) Upgraded to Strong Buy: Here's What You Should Know
Sanara MedTech (NASDAQ:SMTI) Stock Price Up 2% – Here’s Why
Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™
Sanara MedTech: Too Cheap And Better Positioned After Earlier Strategic Missteps
INVESTOR ALERT: Investigation of Sanara MedTech Inc. (SMTI) Announced by Holzer & Holzer, LLC
Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Sanara MedTech Inc. (SMTI) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd